Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy

Webinar Title: Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy

Speakers: Luke Gill, Executive Director, Oncology, Strategic Development, Premier Research and Colin Hayward, Chief Medical Officer, Premier Research

This webinar reviews the current state of technology in gene therapeutics and examines trends in immuno-oncology and gene therapy for hematological malignancies. Topics include:

  • Ingredients for successful study planning and delivery
  • Operationalizing studies to achieve conclusive data outcomes
  • Data-driven approach to choosing the right sites in the right countries
  • Key drivers to retaining patients and meeting study endpoints
  • Exploring future trajectories in outsourcing models for innovative biotech companies

 

 

Phone Us Now
Email Us Now